SEC31A mutation affects ER homeostasis, causing neurological syndrome

D. Halperin, R. Kadir, Y. Perez, M. Drabkin, Y. Yogev, O. Wormser, E. Berman, E. Eremenko, B. Rotblat, Z. Shorer, L. Gradstein, I. Shelef, R. Birk, U. Abdu, H. Flusser, O. S. Birk

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Introduction: Consanguineous kindred presented with an autosomal recessive syndrome of intra-uterine growth retardation, marked developmental delay, spastic quadriplegia with profound contractures, pseudobulbar palsy, epilepsy, dysmorphism, neurosensory deafness and optic nerve atrophy with no eye fixation. Affected individuals died by the age of four. Brain MRI demonstrated microcephaly, semilobar holoprosencephally and agenesis of corpus callosum. We aimed at elucidating the molecular basis of this disease.
Methods: Genome-wide linkage analysis combined with whole exome sequencing were performed to identify disease-causing variants. Functional consequences were investigated in fruit flies null mutant for the Drosophila SEC31A orthologue. SEC31A knockout SH-SY5Y and HEK293T cell-lines were generated using CRISPR/Cas9 and studied through qRT-PCR, immunoblotting and viability assays.
Results: Through genetic studies, we identified a disease-associated homozygous nonsense mutation in SEC31A. We demonstrate that SEC31A is ubiquitously expressed, and that the mutation triggers nonsense mediated decay of its transcript, comprising a practical null mutation. Similar to the human disease phenotype, knockdown SEC31A flies had defective brains and early lethality. Moreover, in line with SEC31A encoding one of the two coating layers comprising the COP-II complex, trafficking newly synthesized proteins from the endoplasmic reticulum to the Golgi, CRISPR/Cas9-mediated SEC31A null mutant cells demonstrated reduced viability through upregulation of ER-stress pathways.
Conclusions: We demonstrate that a severe neurological syndrome is caused by a null mutation in SEC31A, reducing cell viability through enhanced ER-stress response, in line with SEC31A’s role in the COP-II complex. Funding: Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grants no. 1814/13 and 1798/16)
Original languageAmerican English
Pages (from-to)1524-1524
JournalEuropean Journal of Human Genetics
Volume27
StatePublished - Oct 2019

Fingerprint

Dive into the research topics of 'SEC31A mutation affects ER homeostasis, causing neurological syndrome'. Together they form a unique fingerprint.

Cite this